Emergency Response Coordinator Act of 2020
Legislative Progress
Introduced
February 27, 2020
Latest Action
February 27, 2020
Primary Sponsor
Eliot L. EngelDemocratic(NY)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Emergency Response Coordinator Act of 2020 This bill requires the Department of Health and Human Services to designate an official within the department to coordinate federal efforts with respect to COVID-19 (a respiratory disease caused by a novel coronavirus).
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2021 · first_quarter · Health Issues
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the implementation of H.R.5997 - The Emergency Response Coordinator Act of 2020 Issues related to the implementation of H.R.748 - CARES Act Issues relating to Paycheck Protection Program and Health Care Enhancement Act Issues related to coverage and reimbursement of COVID-19 diagnostic tests. Issues related to the Valid Act of 2020. Implementation of Laboratory Access for Beneficiaries (LAB) Act Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related CBC Health Braintrust Clinical Trials Issues related to the PASTEUR Act Issues related to HR 1319/S 2401 Rescue America Plan
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $540,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
2020 · fourth_quarter · Health Issues
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the implementation of H.R.5997 - The Emergency Response Coordinator Act of 2020 Issues related to the implementation of H.R.748 - CARES Act Issues relating to Paycheck Protection Program and Health Care Enhancement Act Issues related to coverage and reimbursement of COVID-19 diagnostic tests. Issues related to the Valid Act of 2020. Implementation of Laboratory Access for Beneficiaries (LAB) Act Improving Medical Device Servicing to Protect Patient Safety Act
Client expense: $540,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2020 · third_quarter · Health Issues
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the implementation of H.R.5997 - The Emergency Response Coordinator Act of 2020 Issues related to the implementation of H.R.748 - CARES Act Issues relating to Paycheck Protection Program and Health Care Enhancement Act Issues related to coverage and reimbursement of COVID-19 diagnostic tests.
Client expense: $750,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · third_quarter · Health Issues
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the implementation of H.R.5997 - The Emergency Response Coordinator Act of 2020 Issues related to the implementation of H.R.748 - CARES Act Issues relating to Paycheck Protection Program and Health Care Enhancement Act Issues related to coverage and reimbursement of COVID-19 diagnostic tests.
Client expense: $750,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · second_quarter · Health Issues
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the implementation of H.R.5997 - The Emergency Response Coordinator Act of 2020 Issues related to the implementation of H.R.748 - CARES Act Issues relating to Paycheck Protection Program and Health Care Enhancement Act Issues related to coverage and reimbursement of COVID-19 diagnostic tests.
Client expense: $540,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · first_quarter · Health Issues
Issues related to implementation of the 21st Century Cures Act Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the implementation of H.R.5997 - The Emergency Response Coordinator Act of 2020 Issues related to the implementation of H.R.748 - CARES Act Issues related to the competitiveness of the medical technology industry and the impact of Federal policies Issues related to implementation of PL 115-271, the SUPPORT Act, and policies related to the opioid crisis
Client expense: $1,400,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE